These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34862072)

  • 1. The Impact of Charlson Comorbidity Index on De Novo Cardiac Implantable Electronic Device Procedural Outcomes in the United States.
    Mohamed MO; Van Spall HGC; Morillo C; Wilton SB; Kontopantelis E; Rashid M; Wu P; Patwala A; Mamas MA
    Mayo Clin Proc; 2022 Jan; 97(1):88-100. PubMed ID: 34862072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Comorbidity Burden on Cardiac Implantable Electronic Devices Outcomes.
    Ajibawo T; Okunowo O; Okunade A
    Clin Med Insights Cardiol; 2022; 16():11795468221108212. PubMed ID: 35783108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends of Sex Differences in Outcomes of Cardiac Electronic Device Implantations in the United States.
    Mohamed MO; Volgman AS; Contractor T; Sharma PS; Kwok CS; Rashid M; Martin GP; Barker D; Patwala A; Mamas MA
    Can J Cardiol; 2020 Jan; 36(1):69-78. PubMed ID: 31740167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REPLACE DARE (Death After Replacement Evaluation) score: determinants of all-cause mortality after implantable device replacement or upgrade from the REPLACE registry.
    Chung MK; Holcomb RG; Mittal S; Steinberg JS; Gleva MJ; Mela T; Uslan DZ; Mitchell K; Poole JE;
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1048-56. PubMed ID: 25221331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and in-hospital outcomes of patients with malignancies undergoing de novo cardiac electronic device implantation in the USA.
    Mohamed MO; Barac A; Contractor T; Silvet H; Arroyo RC; Parwani P; Kwok CS; Martin GP; Patwala A; Mamas MA
    Europace; 2020 Jul; 22(7):1083-1096. PubMed ID: 32361739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Charlson Co-Morbidity Index Score on Management and Outcomes After Acute Coronary Syndrome.
    Zhang F; Bharadwaj A; Mohamed MO; Ensor J; Peat G; Mamas MA
    Am J Cardiol; 2020 Sep; 130():15-23. PubMed ID: 32693918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac implantable electronic device implantation and device-related infection.
    Modi V; Shah K; Ferraro B; Gasimli-Gamache L; Nanda S; Stevens S; Shirani J
    Europace; 2023 Aug; 25(9):. PubMed ID: 37572046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, Outcomes, and Costs According to Patient Frailty Status for 2.9 Million Cardiac Electronic Device Implantations in the United States.
    Mohamed MO; Sharma PS; Volgman AS; Bhardwaj R; Kwok CS; Rashid M; Barker D; Patwala A; Mamas MA
    Can J Cardiol; 2019 Nov; 35(11):1465-1474. PubMed ID: 31679618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Hospital Admissions for and Readmissions After Cardiac Implantable Electronic Device Procedures in the United States: An Analysis From 2010 to 2014 Using the National Readmission Database.
    Pasupula DK; Rajaratnam A; Rattan R; Munir MB; Ahmad S; Adelstein E; Jain S; Wang NC; Saba S
    Mayo Clin Proc; 2019 Apr; 94(4):588-598. PubMed ID: 30853259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of patients with new cardiovascular implantable electronic devices: is adherence to the experts' recommendations associated with improved outcomes?
    Hess PL; Mi X; Curtis LH; Wilkoff BL; Hegland DD; Al-Khatib SM
    Heart Rhythm; 2013 Aug; 10(8):1127-33. PubMed ID: 23773989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of cardiac implantable electronic device transvenous lead extractions performed in centers without onsite cardiac surgery.
    Mohamed MO; Greenspon A; Contractor T; Rashid M; Kwok CS; Potts J; Barker D; Patwala A; Mamas MA
    Int J Cardiol; 2020 Feb; 300():154-160. PubMed ID: 31402163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Disparities in the Choice of Cardiac Resynchronization Therapy Device: An Analysis of Trends, Predictors, and Outcomes.
    Mohamed MO; Contractor T; Zachariah D; van Spall HGC; Parwani P; Minissian MB; Rashid M; Martin GP; Barker D; Patwala A; Mamas MA
    Can J Cardiol; 2021 Jan; 37(1):86-93. PubMed ID: 32376344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States.
    Patel N; Viles-Gonzalez J; Agnihotri K; Arora S; Patel NJ; Aneja E; Shah M; Badheka AO; Pothineni NV; Kancharla K; Mulpuru S; Noseworthy PA; Kusumoto F; Cha YM; Deshmukh AJ
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1425-1435. PubMed ID: 30016005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causes and predictors of 30-day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database.
    Ahmad S; Munir MB; Sharbaugh MS; Althouse AD; Pasupula DK; Saba S
    J Cardiovasc Electrophysiol; 2018 Mar; 29(3):456-462. PubMed ID: 29193418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of infected cardiovascular implantable devices in dialysis patients.
    Opelami O; Sakhuja A; Liu X; Tang WH; Schold JD; Navaneethan SD
    Am J Nephrol; 2014; 40(3):280-7. PubMed ID: 25323128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes of patients undergoing a cardiac implantable electronic device implantation following a recent non-device-related infection.
    Chen HC; Chen YL; Lee WC; Tsai TH; Pan KL; Lin YS; Chen MC
    J Hosp Infect; 2020 Jun; 105(2):272-279. PubMed ID: 32057789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.
    Clémenty N; Carion PL; Léotoing L; Lamarsalle L; Wilquin-Bequet F; Brown B; Verhees KJP; Fernandes J; Deharo JC
    Europace; 2018 Dec; 20(12):1974-1980. PubMed ID: 29672690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Method to Flag Cardiac Implantable Device Infections by Integrating Text Mining With Structured Data in the Veterans Health Administration's Electronic Medical Record.
    Mull HJ; Stolzmann KL; Shin MH; Kalver E; Schweizer ML; Branch-Elliman W
    JAMA Netw Open; 2020 Sep; 3(9):e2012264. PubMed ID: 32955571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac implantable electronic device lead extraction in patients with underlying infection using open thoracotomy or percutaneous techniques.
    Patel D; Khan F; Shah H; Bhattacharya S; Adelstein E; Saba S
    Cardiol J; 2015; 22(1):68-74. PubMed ID: 24846514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.